Marcus E Windrich

Array ( [id] => 847085 [patent_doc_number] => 07384785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'Diagnostic test for West Nile virus' [patent_app_type] => utility [patent_app_number] => 10/839442 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 54152 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/384/07384785.pdf [firstpage_image] =>[orig_patent_app_number] => 10839442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6938579 [patent_doc_number] => 20050112142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Methods and compositions for treatment and prevention of HSV-2 infections and conditions' [patent_app_type] => utility [patent_app_number] => 10/830609 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13589 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112142.pdf [firstpage_image] =>[orig_patent_app_number] => 10830609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275101 [patent_doc_number] => 20040234552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Newcastle disease virus infectious clones, vaccines and new diagnostic assays' [patent_app_type] => new [patent_app_number] => 10/824782 [patent_app_country] => US [patent_app_date] => 2004-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24698 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234552.pdf [firstpage_image] =>[orig_patent_app_number] => 10824782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 141493 [patent_doc_number] => 07687240 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-30 [patent_title] => 'Process for increasing RSV surface glycoprotein yields using a mutant strain of RSV' [patent_app_type] => utility [patent_app_number] => 10/549533 [patent_app_country] => US [patent_app_date] => 2004-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7443 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/687/07687240.pdf [firstpage_image] =>[orig_patent_app_number] => 10549533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 906296 [patent_doc_number] => 07332169 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-19 [patent_title] => 'Newcastle disease virus infectious clones, vaccines and new diagnostic assays' [patent_app_type] => utility [patent_app_number] => 10/788232 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24397 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/332/07332169.pdf [firstpage_image] =>[orig_patent_app_number] => 10788232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5753513 [patent_doc_number] => 20060222662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Composition to be administered to a living being and method for marking agents' [patent_app_type] => utility [patent_app_number] => 10/546031 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10594 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20060222662.pdf [firstpage_image] =>[orig_patent_app_number] => 10546031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7424715 [patent_doc_number] => 20040208886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Composition comprising a parvovirus vp1- variant and a parvovirus ns1 protein for induction of cytolysis' [patent_app_type] => new [patent_app_number] => 10/483234 [patent_app_country] => US [patent_app_date] => 2004-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4373 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20040208886.pdf [firstpage_image] =>[orig_patent_app_number] => 10483234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 830271 [patent_doc_number] => 07399825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'Synthetic peptide, inhibitor to DNA viruses' [patent_app_type] => utility [patent_app_number] => 10/745876 [patent_app_country] => US [patent_app_date] => 2003-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2428 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399825.pdf [firstpage_image] =>[orig_patent_app_number] => 10745876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142519 [patent_doc_number] => 20070004735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Method for inhibiting the replication of herpes viruses' [patent_app_type] => utility [patent_app_number] => 10/541886 [patent_app_country] => US [patent_app_date] => 2003-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17188 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004735.pdf [firstpage_image] =>[orig_patent_app_number] => 10541886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7249772 [patent_doc_number] => 20040258706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Cyanovirin variant-polymer conjugates' [patent_app_type] => new [patent_app_number] => 10/742465 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23832 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20040258706.pdf [firstpage_image] =>[orig_patent_app_number] => 10742465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 390063 [patent_doc_number] => 07300658 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-27 [patent_title] => 'Recombinant poxvirus comprising at least two compox ATI promoters' [patent_app_type] => utility [patent_app_number] => 10/535371 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6699 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/300/07300658.pdf [firstpage_image] =>[orig_patent_app_number] => 10535371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 884116 [patent_doc_number] => 07351547 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-01 [patent_title] => 'Diagnostic test for West Nile virus' [patent_app_type] => utility [patent_app_number] => 10/699550 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 44740 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351547.pdf [firstpage_image] =>[orig_patent_app_number] => 10699550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314681 [patent_doc_number] => 07524651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Assay methods for detection of a virus in an avian tissue sample' [patent_app_type] => utility [patent_app_number] => 10/530073 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 8482 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524651.pdf [firstpage_image] =>[orig_patent_app_number] => 10530073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056377 [patent_doc_number] => 20070059299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection' [patent_app_type] => utility [patent_app_number] => 10/530553 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14257 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059299.pdf [firstpage_image] =>[orig_patent_app_number] => 10530553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7280718 [patent_doc_number] => 20040063095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'gM-negative EHV-mutants' [patent_app_type] => new [patent_app_number] => 10/673017 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7210 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063095.pdf [firstpage_image] =>[orig_patent_app_number] => 10673017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6983842 [patent_doc_number] => 20050153912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Antiviral oligonucleotides targeting viral families' [patent_app_type] => utility [patent_app_number] => 10/661402 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 34868 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153912.pdf [firstpage_image] =>[orig_patent_app_number] => 10661402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7149296 [patent_doc_number] => 20040170959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Methods for identifying antiviral oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/661355 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 35308 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20040170959.pdf [firstpage_image] =>[orig_patent_app_number] => 10661355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 875860 [patent_doc_number] => 07358068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'Antiviral oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/661403 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 120 [patent_no_of_words] => 35047 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358068.pdf [firstpage_image] =>[orig_patent_app_number] => 10661403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894777 [patent_doc_number] => 20060003316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Immunogenic compositions derived from poxviruses and methods of using same' [patent_app_type] => utility [patent_app_number] => 10/620787 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7402 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003316.pdf [firstpage_image] =>[orig_patent_app_number] => 10620787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7004627 [patent_doc_number] => 20050169940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Recombinant poxvirus not having a functional 3beta-hsd gene' [patent_app_type] => utility [patent_app_number] => 10/520371 [patent_app_country] => US [patent_app_date] => 2003-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15255 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169940.pdf [firstpage_image] =>[orig_patent_app_number] => 10520371 [rel_patent_id] =>[rel_patent_doc_number] =>)